Nagui Hassan Fares

Nagui Hassan Fares

Auto-generated profile, based on publicly available information

Nagui Hassan Fares

Zoology Department, Faculty of Science, Ain Shams University, Egypt

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2016 in Journal of Archaeological Science: Reports
Verified
Journal Article
Closed access
WBWalaa A. Basha
Walaa A. Basha
ACAndrew T. Chamberlain
Andrew T. Chamberlain
MZMoushira E. Zaki
Moushira E. Zaki
WKWafaa A. Kandeel
Wafaa A. Kandeel
NFNagui H. Fares
Nagui H. Fares

1 November 1988 in The Anatomical Record
Verified
Journal Article
Closed access
PDF file
NRNahad H. Riad
Nahad H. Riad
MBM. Elizabeth H. Bruns
M. Elizabeth H. Bruns
NFNagui H. Fares
Nagui H. Fares
DBDavid E. Bruns
David E. Bruns
JHJohn C. Herr
John C. Herr

1 July 1987 in Journal of Anatomy
Verified
Journal Article
Closed access
PDF file
JHJohn C. Herr
John C. Herr
NFNagui H. Fares
Nagui H. Fares
MBMohammed A. Banhawy
Mohammed A. Banhawy

9 November 2024 in Microbial Pathogenesis
Verified
Journal Article
Closed access
FAFaten Abozeid
Faten Abozeid
EAEbtisam M. Abdurabbah
Ebtisam M. Abdurabbah
NFNagui H. Fares
Nagui H. Fares
Ahmed A. Al-KarmalawyAhmed A. Al-Karmalawy
Ahmed A. Al-Karmalawy

19 July 2025 in Toxicology Reports
Verified
Journal Article
Open access
HAHoda Abdul-Nabie
Hoda Abdul-Nabie
Safia SamirSafia Samir
Safia Samir
TATarek Aboshousha
Tarek Aboshousha
NFNagui Fares
Nagui Fares
FAFaten Abozeid
Faten Abozeid
Hepatocellular carcinoma (HCC) is a major public health problem, with a poor prognosis in patients with advanced disease. We aimed to investigate the cytotoxic activity of coumestrol against human hepatocellular carcinoma HepG2 cells. Crystal violet (CV) assay was performed for cell cytotoxicity assessment on Vero cells (normal Kidney) and HepG2 cells. Apoptosis was analyzed by Annexin V/FITC staining. The relative expression of BAX, bcl-2, NF-Kβ, PCNA, MMP2, Caspase-3, Caspase-9, COX2, and MMP9 was detected using quantitative real-time PCR (qPCR). In addition, immunohistochemical analysis (IHC) of Bax, and PCNA were established. Results indicated that coumestrol induced significant toxicity in HepG2 cells. Annexin V-FITC staining assays revealed that coumestrol-induced cytotoxicity in HepG2 cells was mediated through apoptosis stimulation. The apoptosis in HepG2 cells was mediated through caspase-activation. Cell invasion was inhibited by coumestrol in HepG2 cells via inhibition of MMP-2 and MMP-9 expressions. IHC confirmed the strong expression of Bax and nuclear expression of PCNA in treated cells. To the best of our knowledge, limited studies have investigated the impact of coumestrol. The study showed that coumestrol exhibited cytotoxic and apoptotic effects against HepG2 cells, accompanied by inhibition of invasion-related gene expression.

1 February 1998
Verified
Journal Article
Closed access
AEA Abd El-Aal
A Abd El-Aal
NFN H Fares
N H Fares